Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Alpenglow Biosciences Secures $24M with ARPA-H and NIH for Development of 3D Spatial Pathology Platform

Aug 15, 2024•almost 2 years ago

Contract Type

partnership

SeattleHealthcareHealth Care

Description

Alpenglow Biosciences, in partnership with the Liu Biophotonics Lab at University of Washington, the Mahmood AI Lab at Harvard & Mass General Brigham, and Vanderbilt University Medical Center, has secured a total investment of $24M for the development of its 3D spatial pathology platform. The partnership aims to revolutionize surgical oncology by providing near real-time, high-resolution 3D imaging to identify tumor margins with unprecedented accuracy.

Company Information

Company

Alpenglow Biosciences

Location

2121 N 35TH STREET, SUITE 100

Seattle, Washington, United States

About

Alpenglow Biosciences accelerates drug development and improves clinical diagnostics with light-sheet 3D tissue imaging and AI-powered analysis for spatial biology and digital pathology. The Aurora 3D spatial biology platform digitizes intact tissue samples, delivering quantitative 3D datasets while preserving tissue for molecular analysis.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Alpenglow Biosciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.